CochLear Price to Book Ratio 2023-2024 | CHEOY
Historical price to book ratio values for CochLear (CHEOY) over the last 10 years. The current price to book ratio for CochLear as of May 28, 2025 is 9.59.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| CochLear Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2025-05-27 | 88.40 | 0.00 | |
| 2024-06-30 | 109.21 | 0.00 | |
| 2023-06-30 | 74.11 | 0.00 | |
| 2022-06-30 | 65.48 | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $11.562B | $1.488B |
| Cochlear Limited provides implantable hearing solutions principally in the Americas, Europe, the Middle East, Africa and the Asia Pacific. The company offers cochlear implants, including Nucleus 7 and Kanso sound processors; Carina middle-ear implants and accessories and Baha bone conduction implants. Cochlear Limited is based in Sydney, Australia. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $135.390B | 25.39 |
| Elevance Health (ELV) | United States | $84.947B | 10.96 |
| CVS Health (CVS) | United States | $77.596B | 9.64 |
| Cencora (COR) | United States | $56.866B | 19.78 |
| DiDi Global (DIDIY) | China | $22.921B | 34.79 |
| Natera (NTRA) | United States | $21.460B | 0.00 |
| BioMerieux (BMXMF) | France | $15.355B | 0.00 |
| Solventum (SOLV) | United States | $12.549B | 13.28 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.465B | 0.00 |
| Revvity (RVTY) | United States | $10.871B | 18.71 |
| ICON (ICLR) | Ireland | $10.610B | 9.86 |
| Viatris (VTRS) | United States | $10.094B | 3.47 |
| Doximity (DOCS) | United States | $9.727B | 45.30 |
| Avantor (AVTR) | United States | $8.961B | 13.02 |
| HealthEquity (HQY) | United States | $8.748B | 43.04 |
| Medpace Holdings (MEDP) | United States | $8.582B | 22.79 |
| Sonic Healthcare (SKHHY) | Australia | $8.220B | 0.00 |
| Charles River Laboratories (CRL) | United States | $6.810B | 13.35 |
| Amplifon S.p.A (AMFPF) | Italy | $4.966B | 27.18 |
| Bausch + Lomb (BLCO) | Canada | $4.171B | 24.58 |
| BrightSpring Health Services (BTSG) | United States | $4.074B | 37.71 |
| Sotera Health (SHC) | United States | $3.528B | 20.05 |
| Surgery Partners (SGRY) | United States | $2.954B | 38.42 |
| Alignment Healthcare (ALHC) | United States | $2.920B | 0.00 |
| Concentras Parent (CON) | United States | $2.761B | 15.96 |
| Organon (OGN) | United States | $2.376B | 2.52 |
| Ardent Health Partners (ARDT) | United States | $2.127B | 9.07 |
| GeneDx Holdings (WGS) | United States | $1.997B | 76.91 |
| Premier (PINC) | United States | $1.896B | 14.39 |
| Progyny (PGNY) | United States | $1.765B | 38.85 |
| PACS (PACS) | United States | $1.558B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.368B | 27.36 |
| Teladoc Health (TDOC) | United States | $1.242B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.190B | 9.05 |
| Establishment Labs Holdings (ESTA) | $1.067B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $0.998B | 0.00 |
| CareDx (CDNA) | United States | $0.982B | 15.33 |
| Agilon Health (AGL) | United States | $0.923B | 0.00 |
| Nutex Health (NUTX) | United States | $0.911B | 13.77 |
| AMN Healthcare Services Inc (AMN) | United States | $0.822B | 7.70 |
| QDM (QDMI) | Hong Kong, SAR China | $0.743B | 0.00 |
| Embecta (EMBC) | United States | $0.658B | 4.43 |
| InnovAge Holding (INNV) | United States | $0.545B | 0.00 |
| Enhabit (EHAB) | United States | $0.529B | 43.54 |
| LifeMD (LFMD) | United States | $0.524B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.484B | 10.90 |
| SBC Medicals (SBC) | United States | $0.477B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.471B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.400B | 0.00 |
| Oncology Institute (TOI) | United States | $0.269B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.220B | 0.00 |
| Beauty Health (SKIN) | United States | $0.213B | 0.00 |
| KindlyMD (NAKA) | United States | $0.151B | 0.00 |
| KindlyMD (KDLY) | United States | $0.150B | 0.00 |
| DocGo (DCGO) | United States | $0.142B | 23.17 |
| OncoCyte (OCX) | United States | $0.093B | 0.00 |
| So-Young (SY) | China | $0.090B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.063B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.063B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.063B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| Biodesix (BDSX) | United States | $0.051B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.038B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.020B | 0.00 |
| ModivCare (MODV) | United States | $0.013B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.013B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.010B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.008B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.007B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |